CIK 0001157075 · Non-accelerated filer<br>Smaller reporting company
PharmaCyte Biotech, Inc.
Sign in to watch- Ticker
- PMCB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Apr 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 621772151
- Phone
- (917) 595.2850
- Business address
- 3960 HOWARD HUGHES PARKWAY, SUITE 500, LAS VEGAS, NV, 89169
- Former names
- NUVILEX, INC., EFOODSAFETY COM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-12 | SCHECHTER JONATHAN Director | Grant or award | +150,000 | 200,000 | ||
| 2025-12-12 | SCHECHTER JONATHAN Director | Shares withheld for taxes | −67,500 | $1.02 | $69K | 132,500 |
| 2025-12-12 | Abecassis Michael M Director | Grant or award | +37,500 | 39,167 | ||
| 2025-12-12 | Abecassis Michael M Director | Shares withheld for taxes | −16,875 | $1.02 | $17K | 22,292 |
| 2025-04-25 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | ||
| 2025-04-25 | WALKER WAYNE REMELL Director | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | ||
| 2025-04-25 | SCHECHTER JONATHAN Director | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | ||
| 2025-04-25 | Abecassis Michael M Director | Grant or award · Stock Option (Right to Buy) | +63,233 | 63,233 | ||
| 2024-04-30 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +38,009 | 38,009 | ||
| 2024-04-30 | WALKER WAYNE REMELL Director | Grant or award · Stock Option (Right to Buy) | +38,009 | 38,009 | ||
| 2024-04-30 | SCHECHTER JONATHAN Director | Grant or award · Stock Option (Right to Buy) | +38,009 | 38,009 | ||
| 2024-04-30 | Abecassis Michael M Director | Grant or award · Stock Option (Right to Buy) | +38,009 | 38,009 | ||
| 2023-11-20 | WEINSTEIN ROBERT Director | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 | ||
| 2023-11-20 | WALKER WAYNE REMELL Director | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 | ||
| 2023-11-20 | Trujillo Carlos Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2023-11-20 | Silverman Joshua Interim CEO, Interim President | Grant or award · Stock Option (Right to Buy) | +170,000 | 170,000 | ||
| 2023-11-20 | SCHECHTER JONATHAN Director | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 | ||
| 2023-11-20 | Abecassis Michael M Director | Grant or award · Stock Option (Right to Buy) | +61,248 | 61,248 | ||
| 2022-12-28 | Farb Daniel Stuart Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 | ||
| 2022-12-28 | Allen Daniel Director | Grant or award · Stock Option (Right to Buy) | +125,000 | 125,000 |
Page 2 of 2 · 40 trades